These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28464039)

  • 21. VP22 mediates intercellular trafficking and enhances the in vitro antitumor activity of PTEN.
    Yu X; Xu Z; Lei J; Li T; Wang Y
    Mol Med Rep; 2015 Jul; 12(1):1286-90. PubMed ID: 25816150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress.
    Luo S; Lei K; Xiang D; Ye K
    Oxid Med Cell Longev; 2018; 2018():9146528. PubMed ID: 30595797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulation of tissue factor expression by anti-oncogene PTEN in human neuroblastoma cell line].
    Fang J; Tang H; Xia LH; Wei WN; Hu Y; Song SJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):363-6. PubMed ID: 17939398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
    Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
    Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.
    Pore N; Liu S; Haas-Kogan DA; O'Rourke DM; Maity A
    Cancer Res; 2003 Jan; 63(1):236-41. PubMed ID: 12517803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway.
    Sun Y; Tian H; Wang L
    Oncol Rep; 2015 Apr; 33(4):1828-36. PubMed ID: 25683168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines.
    Akca H; Demiray A; Aslan M; Acikbas I; Tokgun O
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):539-44. PubMed ID: 22299584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
    Benitez JA; Ma J; D'Antonio M; Boyer A; Camargo MF; Zanca C; Kelly S; Khodadadi-Jamayran A; Jameson NM; Andersen M; Miletic H; Saberi S; Frazer KA; Cavenee WK; Furnari FB
    Nat Commun; 2017 May; 8():15223. PubMed ID: 28497778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling.
    Xu B; Jiang C; Han H; Liu H; Tang M; Liu L; Ji W; Lu X; Yang X; Zhang Y; Liu Y
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1296-307. PubMed ID: 26356761
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
    Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
    [No Abstract]   [Full Text] [Related]  

  • 34. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
    Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
    Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between PTEN mutations and protein kinase B phosphorylation caused by insulin or recombinant human epidermal growth factor stimulation].
    Zhong H; Hu X; Lin J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1065-8. PubMed ID: 27412938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells].
    Zhai YN; Xu LL; Shen Y; Xia H; Shen YF
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):682-5. PubMed ID: 21092549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
    Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
    Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells.
    Huang WJ; Lin CW; Lee CY; Chi LL; Chao YC; Wang HN; Chiou BL; Chen TJ; Huang CY; Chen CN
    J Ethnopharmacol; 2011 Jun; 136(1):156-67. PubMed ID: 21530633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.